PULMATRIX, INC. Business Acquisition, Pro Forma Net Income (Loss)
PULMATRIX, INC. (PULM) reported Business Acquisition, Pro Forma Net Income (Loss) of -$19.09 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2017-03-10
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for the quarter ending 2015-12-31 was -$4.54M.
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for the quarter ending 2015-09-30 was -$4.93M.
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for the quarter ending 2015-06-30 was $6.17M.
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for the quarter ending 2015-03-31 was -$15.79M.
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for fiscal 2015 was -$19.09M.
- PULMATRIX, INC. business acquisition, pro forma net income (loss) for fiscal 2014 was -$33.46M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | -$4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$9.47M derived: sum of 2 quarters · filed 2017-03-10 | -$3.30M derived: sum of 3 quarters · filed 2017-03-10 | -$19.09M 10-K · filed 2017-03-10 | |
| 2015-09-30 | -$4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.24M derived: sum of 2 quarters · filed 2016-08-04 | -$14.56M 10-Q · filed 2015-11-12 | -$18.82M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-06-30 | $6.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$9.63M 10-Q · filed 2016-08-04 | -$10.89M 10-Q · filed 2015-08-14 | -$13.89M derived: sum of 3 quarters · filed 2016-08-04 | -$26.74M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | -$15.79M 10-Q · filed 2016-05-05 | -$20.06M derived: sum of 2 quarters · filed 2016-05-05 | -$32.91M derived: sum of 3 quarters · filed 2016-05-05 | ||
| 2014-12-31 | -$4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$17.11M derived: sum of 2 quarters · filed 2016-03-10 | -$33.46M 10-K · filed 2016-03-10 | ||
| 2014-09-30 | -$12.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$29.20M 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | -$16.35M 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |